Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15641055

Download in:

View as

General Info

PMID
15641055